Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group.
Mancuso M, Papadopoulou MT, Ng YS, Ardissone A, Bellusci M, Bertini E, Di Vito L, Evangelista T, Fons C, Hikmat O, Horvath R, Klopstock T, Kornblum C, Lamperti C, Licchetta L, Molnar MJ, Varhaug KN, O'Callaghan M, Pressler RM, Schiff M, Servidei S, Szabo N, Gorman GS, Cross JH, Rahman S.
Mancuso M, et al.
Eur J Neurol. 2024 Apr 4:e16275. doi: 10.1111/ene.16275. Online ahead of print.
Eur J Neurol. 2024.
PMID: 38576261
Exceptions including valproic acid in POLG disease, vigabatrin in patients with gamma-aminobutyric acid transaminase deficiency and topiramate in patients at risk for renal tubular acidosis were highlighted. ...
Exceptions including valproic acid in POLG disease, vigabatrin in patients with gamma-aminobutyric acid transaminase …